RSS feed

Meet Cardiomedex at AFSTAL (booth n°122) in Toulouse, France, 4-6 June 2014

May 16, 2014

We are pleased to announce that Dr Sulpice, Cardiomedex and Physiogenex’s CEO,  will present on Wednesday, 4th regarding “the choice of predictive animal models for an improved predictivity of future clinical trials”.

During the conference, come and meet Dr Caroline Dubroca, head of the preclinical platform in Physiogenex’s booth.  She will be very pleased to discuss with you about your projects and present our services and capabilities.

Read more

Drug Discovery Innovation Congress, Berlin, Germany, 19-20 March, 2013

Feb 3, 2013

We are pleased to inform that Dr Céline Gales will be speaking on BRET based G protein activation during  the session “Advances in Target Based Drug Design” dealing with the understanding of the biological consequences of signalling pathways and GPCR functions and the evalutation of the mechanism of action of receptors and approaches for translating allosteric modulators into the clinic.

Dr Gales’s presentation is entitled “Delineating the Complexity of Biased and Full Agonism Reveals the Existence of a New Distinct Active AT1 Receptor Entity: Toward a Redefinition of “Biased Agonist”.”

To meet Dr Gales during the conference or for more information on BRET based assays, feel fee to contact us.

Link with Drug Discovery Innovation, Berlin, Germany, 19-20 March 2013

felis libero. commodo Sed adipiscing neque. Curabitur